Top recent neuroendocrinology and adrenal news
Click Here to Manage Email Alerts
Endocrine Today has compiled a list of the top recent news reports focused on neuroendocrinology and adrenal medicine.
Healio readers were interested in the effects of pheochromocytoma and paraganglioma on osteoporosis development, how adrenal incidentalomas influence type 2 diabetes risk, early glucocorticoid treatment and more.
Pheochromocytoma, paraganglioma underrecognized cause of secondary osteoporosis
Adults with pheochromocytoma or paraganglioma are nearly five times more likely to experience a vertebral fracture, a hallmark of osteoporosis, when compared with adults with nonfunctional adrenal tumors.
Long-term obesity persists despite pituitary adenoma treatment in childhood
Obesity is common at diagnosis of pituitary adenoma in childhood and may persist despite successful treatment.
Adrenal incidentalomas tied to increased risk for type 2 diabetes
An analysis of unselected adults who underwent a CT scan suggests that those who had an unsuspected adrenal tumor were more likely to have type 2 diabetes, although it is unclear whether cortisol secretion influences any risk.
Early glucocorticoid treatment in congenital adrenal hyperplasia may boost cognitive function
Children and adolescents with congenital adrenal hyperplasia, or CAH, diagnosed early via a neonatal screening program and treated with hydrocortisone had normal psychometric intelligence and executive function compared with population controls.
Pasireotide reduces pituitary tumor volume in Cushing’s disease
Most adults with persistent or recurrent Cushing’s disease treated with the somatostatin analogue pasireotide experienced a measurable decrease in MRI-detectable pituitary tumor volume at 12 months.